Skip to content
NCD MALAYSIA 2026Conference · 27–29 Nov 2026
03 — Call for abstracts

Present your work at NCDM 2026.

All abstracts accepted for presentation will be published in a Scopus-indexed international journal.

  1. Call for abstracts opens

    12 October 2026

  2. Call for abstracts closes

    7 November 2026

    11:59 pm MYT

  3. Acceptance notification

    15 November 2026

  4. Abstract withdrawal closes

    20 November 2026

    11:59 pm MYT

Before you submit

Downloads & portal

At a glance

Length
Up to 300 words — background, aims, methods, results, conclusions. No illustrations, tables or figures.
Authors
Up to 20 authors per abstract, each with full name, institution, email and a completed disclosure form.
Fee
No fee to submit. Once accepted, presenters must register for the conference and pay the applicable registration fee.
Capacity
Up to 150 abstracts will be accepted. Submissions may be reviewed and accepted on a rolling basis, so submit early.
Format
Rapid-fire oral: 3 minutes + 2 minutes Q&A, maximum 5 slides.
Indexing
Accepted abstracts are published in a Scopus-indexed journal.
Themes

Choose the one theme that fits your abstract.

Select the theme that most accurately aligns with the content of the abstract. The NCDM Scientific Committee may recategorise an abstract where necessary.

  1. Theme 1

    Prevention, Risk Reduction, Screening & Early Detection

    NCD prevention, risk reduction, health promotion, screening, early detection, diagnostic pathways, risk assessment, lifestyle interventions, health literacy, environmental and occupational risk factors, and community-based prevention initiatives.

  2. Theme 2

    Treatment, Integrated Care & Long-Term Management

    NCD treatment, clinical management, multidisciplinary and integrated care, primary and specialist care, multimorbidity, medication management, care coordination, long-term disease management, treatment outcomes, and models of chronic care.

  3. Theme 3

    Living Well, Rehabilitation, Supportive Care & Quality of Life

    Rehabilitation, functional recovery, supportive and palliative care, nutrition, physical activity, psychosocial support, self-management, treatment burden, caregiver support, disability, healthy ageing, survivorship, and quality of life among people living with NCDs.

  4. Theme 4

    Innovation, Digital Health, Precision Medicine & Emerging Science

    Emerging diagnostics and therapies, precision medicine, genomics, biomarkers, artificial intelligence, digital health, telehealth, remote monitoring, medical technology, innovative models of care, and other scientific or technological advances relevant to NCD prevention and management.

  5. Theme 5

    Access, Equity, Health Systems, Policy & Advocacy

    Access to NCD services and medicines, health equity, health financing, health systems, primary care strengthening, implementation research, health policy, advocacy, civil society action, patient engagement, social and commercial determinants of health, and strategies to strengthen NCD prevention and care at the population level.

Guidelines

Submission guidelines

Key points from the NCDM 2026 Abstract Submission Guideline (PDF above), which applies where anything here differs.

Information to note before submission

  • Create an account on the NCDM 2026 abstract submission portal. Any co-author may submit.
  • The submitting author need not be the first author, but must select who the first author is.
  • After the submission deadline, no edits or resubmissions are permitted. Abstracts are published as submitted; the organisers do not proofread.
  • Complete the NCDM Disclosure Form for every author. The submitting author may upload on behalf of co-authors who have authorised them to do so.
  • Choose the one theme that most accurately fits the abstract. The Scientific Committee may recategorise it.
  • The title should reflect the entire study, not only the results. The Scientific Committee may edit titles where appropriate.

Eligibility

  • Submissions must be in English.
  • Any abstract related to noncommunicable diseases is welcome, including high-impact case studies and reports.
  • Abstracts must include scientific data, clinical observations or a clearly stated scientific question.
  • Social science, advocacy, policy, social marketing and programme-implementation abstracts are exempt from the scientific structure and are judged on novelty and innovation.
  • Previously presented trial data may be submitted if it adds significant new data.
  • Multiple abstracts reporting a single study may be rejected.

First author responsibilities

  • Consents to the Confidentiality Policy.
  • Acts as the contact person for the submission.
  • Ensures ethics-committee approval and consent where required.
  • Ensures every co-author is aware of and agrees with the content.
  • Hands over copyright to the NCDM 2026 Scientific Committee.
  • Uses the same contact information across all of their abstracts.
  • Designates the corresponding author in the portal.

Selection & presentation

  • Every abstract is screened by the Scientific Committee.
  • Accepted authors must register for the conference, or the acceptance is cancelled.
  • Delegates who registered before acceptance are converted to presenters.
Awards

Merit Awards

For non-student submissions.

  • Merit Awards are conferred on the highest-scoring accepted abstract presentations.
  • Recipients are screened and selected by the NCDM 2026 Scientific Committee, whose decision is final.
  • Award recipients are announced on the final day of the congress.
  • Recipients are honoured with a trophy plaque, a Certificate of Merit and waived conference registration fees.

Applicants must be the first author on the abstract submission.

Policies
Prior presentation or publication
Work already presented at a conference or published may be considered if it adds new data. Pre-prints are allowed.
Disclosure & funding
Every author discloses financial interests, funding sources, affiliations and other potential conflicts on the Disclosure Form. State the funding source, grant number and awarding organisation where applicable, and whether the funder had any role in the study. Abstracts funded in whole or in part by the tobacco or vaping industry are not accepted.
Generative AI
Generative AI may not be used to write abstracts. AI-generated submissions are rejected.

Questions or withdrawals: email [email protected] before 20 November 2026, 11:59 pm MYT.

Presenting? Register at the presenter rate.

Accepted abstract presenters qualify for the special presenter rate. See registration fees.